Pentadeca Arginate (PDA)
Overview
Pentadeca Arginate is a synthetic 15-arginine polypeptide designed to enhance cellular uptake and delivery of therapeutic molecules. The polyarginine structure confers cell-penetrating properties by interacting with negatively charged cell membrane components. It has been explored as a carrier for facilitating intracellular delivery of bioactive compounds and as a potential modulator of tissue repair processes.
Key Research Findings
Preclinical in vitro studies have demonstrated efficient cellular internalization and low cytotoxicity in various cell lines. Animal studies investigating wound healing and tissue repair applications have shown preliminary evidence of enhanced regeneration, though mechanisms remain incompletely characterized. No clinical trial data in humans are currently available.
Subcutaneous injection, Topical
Research Phase
Interested in Pentadeca Arginate (PDA)?
Find a verified provider experienced with Pentadeca Arginate (PDA) protocols in your area. All providers are credentialed and use compliant sourcing.
Find a Pentadeca Arginate (PDA) ProviderRelated Peptides
BPC-157
Research PhaseA synthetic gastric pentadecapeptide derived from a protein found in human gastric juice. BPC-157 promotes angiogenesis and the expression of growth factors including VEGF, EGF, and NO-mediated pathways. It has demonstrated cytoprotective and wound-healing properties across multiple tissue types in preclinical models, including tendon, muscle, ligament, and gastrointestinal mucosa.
TB-500 (Thymosin Beta-4)
In Clinical TrialsThymosin Beta-4 is a 43-amino acid actin-sequestering protein involved in cell migration, differentiation, and tissue repair. It promotes wound healing by upregulating cell-building proteins such as actin and laminin, facilitating cell migration to sites of injury. TB-500 also has anti-inflammatory properties mediated through NF-kB pathway modulation.
GHK-Cu
Research PhaseA naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) found in human plasma, saliva, and urine. GHK-Cu activates tissue remodeling by stimulating collagen synthesis, glycosaminoglycan production, and angiogenesis while suppressing fibrinogen synthesis. It modulates the activity of matrix metalloproteinases and influences over 4,000 genes related to tissue repair.
DSIP (Delta Sleep-Inducing Peptide)
Research PhaseA naturally occurring nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) originally isolated from cerebral venous blood of rabbits during induced sleep. DSIP modulates sleep architecture by promoting delta wave (slow-wave) sleep through interactions with the GABAergic system and hypothalamic sleep centers. It also exhibits stress-protective, analgesic, and neuromodulatory properties.